Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) has announced the availability of its first quarter fiscal year 2026 financial results on its Investor Relations website. The company will host a conference call and webcast with investors and analysts on August 7, 2025, at 8:00 a.m. ET to discuss the results.
The conference call requires pre-registration, and participants are recommended to join 10 minutes before the event. A replay of the conference call and webcast will be accessible for one year starting from August 7, 2025, at 11:00 a.m. ET.
Haemonetics Corporation (NYSE: HAE) ha annunciato la pubblicazione dei risultati finanziari del primo trimestre dell'anno fiscale 2026 sul sito web dedicato agli Investitori. L'azienda terrà una conference call e una webcast con investitori e analisti il 7 agosto 2025 alle 8:00 ET per discutere i risultati.
La partecipazione alla conference call richiede la registrazione anticipata, e si consiglia ai partecipanti di collegarsi 10 minuti prima dell'inizio. La registrazione della conference call e della webcast sarà disponibile per un anno a partire dal 7 agosto 2025 alle 11:00 ET.
Haemonetics Corporation (NYSE: HAE) ha anunciado la publicación de sus resultados financieros del primer trimestre del año fiscal 2026 en su sitio web de Relaciones con Inversores. La compañía realizará una llamada en conferencia y una transmisión en vivo con inversores y analistas el 7 de agosto de 2025 a las 8:00 a.m. ET para discutir los resultados.
La llamada en conferencia requiere preinscripción, y se recomienda a los participantes conectarse 10 minutos antes del evento. La repetición de la llamada y la transmisión estará disponible durante un año a partir del 7 de agosto de 2025 a las 11:00 a.m. ET.
Haemonetics Corporation (NYSE: HAE)는 2026 회계연도 1분기 재무 결과를 투자자 관계 웹사이트에 공개했다고 발표했습니다. 회사는 2025년 8월 7일 오전 8시 ET에 투자자 및 애널리스트와의 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
컨퍼런스 콜은 사전 등록이 필요하며, 참가자들은 행사 시작 10분 전에 접속하는 것이 권장됩니다. 컨퍼런스 콜과 웹캐스트 녹화는 2025년 8월 7일 오전 11시 ET부터 1년간 다시 보기로 제공됩니다.
Haemonetics Corporation (NYSE : HAE) a annoncé la mise à disposition de ses résultats financiers du premier trimestre de l'exercice 2026 sur son site web dédié aux relations investisseurs. La société organisera une conférence téléphonique et un webcast avec les investisseurs et analystes le 7 août 2025 à 8h00 ET pour discuter des résultats.
La participation à la conférence téléphonique nécessite une inscription préalable, et il est recommandé aux participants de se connecter 10 minutes avant le début de l'événement. Le replay de la conférence téléphonique et du webcast sera accessible pendant un an à partir du 7 août 2025 à 11h00 ET.
Haemonetics Corporation (NYSE: HAE) hat die Veröffentlichung der Finanzergebnisse für das erste Quartal des Geschäftsjahres 2026 auf seiner Investor-Relations-Website bekannt gegeben. Das Unternehmen wird am 7. August 2025 um 8:00 Uhr ET eine Telefonkonferenz und Webcast mit Investoren und Analysten abhalten, um die Ergebnisse zu besprechen.
Für die Telefonkonferenz ist eine Voranmeldung erforderlich, und Teilnehmer werden empfohlen, sich 10 Minuten vor Beginn einzuwählen. Eine Aufzeichnung der Telefonkonferenz und des Webcasts wird ab dem 7. August 2025 um 11:00 Uhr ET für ein Jahr verfügbar sein.
- None.
- None.
Financial release accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025. The conference call and webcast can be accessed with the following information:
- Teleconference link:
https://register-conf.media-server.com/register/BIb1de2bd7b8ba4267b7bc38da4e4008c7 - Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/wv7zkgdh
In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.
Direct link to 1Q FY26 Earnings Release:
https://haemonetics.gcs-web.com/static-files/078498e0-b75c-4cd4-94fb-93730b3b1c70
A replay of the conference call and webcast will be available for one year beginning on August 7, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: Josh Gitelson, Sr. Director-Global Communications (781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website-302523396.html
SOURCE Haemonetics Corporation
FAQ
When is Haemonetics (HAE) Q1 FY2026 earnings call scheduled?
How can investors access Haemonetics' Q1 FY2026 earnings results?
How long will Haemonetics' Q1 FY2026 earnings call replay be available?
What is the registration process for Haemonetics' Q1 FY2026 earnings call?
